Abstract
p53 induces the transcription of genes that negatively regulate progression of the cell cycle in response to DNA damage or other cellular stressors, and thus participates in maintaining genome stability. Under stress conditions, p53 must be activated to prohibit the replication of cells containing damaged DNA. However, in normal, non-stressed cells, p53 activity must be inhibited. Previous studies have demonstrated that p53 transcription is activated before or during early S-phase in cells progressing from G0/G1 into S-phase. Since this is not what would be predicted from a gene involved in growth arrest and apoptosis, in this study, we provide evidence that this induction occurs to provide sufficient p53 mRNA to ensure a rapid response to DNA damage before exiting S-phase. When comparing exponentially growing Swiss3T3 cells to those synchronized to enter S-phase simultaneously and treated with the DNA damaging agent camptothecin, we found that with cells in S-phase, p53 protein levels increased earlier, Bax and p21 transcription was activated earlier and to a greater extent and apoptosis occurred earlier and to a greater extent. These findings are consistent with p53 transcription being induced in S-phase to provide for a rapid DNA-damage response during S-phase of the cell cycle.
Similar content being viewed by others
References
Horn HF, Vousden KH (2007) Coping with stress: multiple ways to activate p53. Oncogene 26:1306–1316
Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137:413–431
Agarwal ML, Agarwal A, Taylor WR, Chernova O, Sharma Y, Stark GR (1998) A p53- dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proc Natl Acad Sci USA 95:14775–14780
Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358:15–16
Attardi LD, Jacks T (1999) The role of p53 in tumour suppression: lessons from mouse models. Cell Mol Life Sci 55:48–63
Reich NC, Levine AJ (1984) Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature 308:199–201
Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, Deppert W (1995) Negative feedback regulation of wild-type p53 biosynthesis. EMBO J 14:4442–4449
Oren M, Rotter V (1999) Introduction: p53–the first twenty years. Cell Mol Life Sci 5:9–11
Barak Y, Juven T, Haffner R, Oren M (1993) mdm2 expression is induced by wild type p53 activity. EMBO J 12:461–468
Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM (2000) Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275:8945–8951
Yee KS, Vousden KH (2005) Complicating the complexity of p53. Carcinogenesis 26:1317–1322
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304–6311
Menendez D, Inga A, Resnick MA (2009) The expanding universe of p53 targets. Nat Rev Cancer 10:724–737
Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139:1281–1292
Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47–59
Gottifredi V, McKinney K, Poyurovsky MV, Prives C (2004) Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block. J Biol Chem 279:5802–5810
Janus F, Albrechtsen N, Dornreiter I, Wiesmüller L, Grosse F, Deppert W (1999) The dual role model for p53 in maintaining genomic integrity. Cell Mol Life Sci 55:12–27
Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803–1815
Reed JC, Alpers JD, Nowell PC, Hoover RG (1986) Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. Proc Natl Acad Sci USA 83:3982–3986
Ginsberg D, Oren M, Yaniv M, Piette J (1990) Protein-binding elements in the promoter region of the mouse p53 gene. Oncogene 5:1285–1290
Boggs K, Reisman D (2006) Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter. Oncogene 25:555–565
Horwitz SB, Chang CK, Grollman AP (1971) Studies on camptothecin: I. Effects on nucleic acid and protein synthesis. Mol Pharmacol 7:632–644
Hsiang YH, Hertzberg R, Hecht S, Liu LF (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260:14873–14878
Mei Y, Xie C, Xie W, Tian X, Li M, Wu M (2007) Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis. Neoplasia 9:871–881
Fink R, Fink K (1962) Utilization of radiocarbon from thymidine and other precursors of ribonucleic acid in Neurospora crassa. J Biol Chem 237:2289–2290
Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A et al (2001) Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem 276:15164–15173
Boggs K, Reisman D (2007) The transcription factor C/EBP is essential for cell cycle regulation of the p53 gene. J. Biol. Chem. 282:7982–7990
Polson A, Takahashi P, Reisman D (2010) Chromatin Immunoprecipitation (ChIP) Analysis Demonstrates Coordinated Binding of Two Transcription Factors to the Promoter of the p53 Tumor Suppressor Gene. Cell Biol Int 34:883–891
Offer H et al (2001) p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress. Cancer Res 61:88–96
Jin S, Levine AJ (2001) The p53 functional circuit. J Cell Sci 114:4139–4140
Firlej V, Bocquet B, Desbiens X, de Launoit Y, Chotteau-Lelièvre A (2005) Pea3 transcription factor cooperates with USF-1 in regulation of the murine bax transcription without binding to an Ets-binding site. J Biol Chem 280:887–898
Gottifredi V, Shieh S, Taya Y, Prives C (2001) p53 accumulates but is functionally impaired when DNA synthesis is blocked. Proc Natl Acad Sci USA 98:1036–1041
Zhang XP, Lui F, Wang W (2010) Coordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage. J Biol Chem 285:31571–31580
Acknowledgments
This work was supported by the Biomedical Research Infrastructure Networks (BRIN), and the South Carolina IDEA-Collaborative Research Program.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takahashi, P., Polson, A. & Reisman, D. Elevated transcription of the p53 gene in early S-phase leads to a rapid DNA-damage response during S-phase of the cell cycle. Apoptosis 16, 950–958 (2011). https://doi.org/10.1007/s10495-011-0623-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-011-0623-z